Evidence-Based Reflux Management Strategies - June 21, 2022

Gastroesophageal reflux disease (GERD) affects as much as a third of western populations. Proton pump inhibitors, the initial therapy for typical symptoms, fail in up to 40% of patients. The management of these nonresponders poses significant challenges clinically and, when patients remain symptomatic for many years, delays in treatment can increase costs and worsen outcomes. This course will review the modern diagnostic and treatment strategies for patients presenting with both typical (heartburn, regurgitation, chest pain) and atypical (cough, hoarseness, choking) symptoms.
When Jun 21, 2022
from 06:00 PM to 07:00 PM
Where Virtual Event
Contact Name
Contact Phone 502-424-8806
Add event to calendarvCal


Target Audience
Primary Care Providers and Gastroenterologists

6:00 - 6:05 pm
Welcome & Introductions        
Benjamin Rogers, MD and Farid Kehdy, MD

6:05 - 6:10 pm
GERD Defined                                
Benjamin Rogers, MD

6:10 - 6:25 pm
Proper medical treatment of GERD                    
Benjamin Rogers, MD

6:25 - 6:30 pm
Indications for escalation of therapy         
Benjamin Rogers, MD

6:30 - 6:50 pm
Surgical approaches for management of GERD    
Farid Kehdy, MD

6:50 - 7:00 pm
Questions & Answers                
Benjamin Rogers, MD and Farid Kehdy, MD

7:00 pm
Adjournment & Evaluations               
Farid Kehdy, MD

Course Director
 Farid Kehdy, MD

UofL School of Medicine Associate Professor, Department of Surgery
UofL Physicians - General Surgeon
UofL Health – Chestnut Street Outpatient Center
401 East Chestnut Street, Suite 710
Louisville, KY 40202

Participating Faculty
 Benjamin Rogers, MD
UofL School of Medicine Assistant Professor, Department of Medicine
UofL Health – Gastroenterologist
UofL Health GI Motility Clinic
Jewish Hospital Outpatient Care Center
225 Abraham Flexner Way, Suite 502, Louisville, KY 40202

Learning Objectives

As a result of participating in this activity, participants should be able to:

1. Define reflux disease.
2. Identify indications for escalation of therapy.
3. Describe proper medical treatment modalities for management of GERD.
4. List surgical approaches for management of GERD.

Continuing Education Credit
 Physician Credit
- The University of Louisville Continuing Medical Education office designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Special Services

All individuals are encouraged to participate. To request disability arrangements, please contact  at 502-424-8806 at least 14 days prior to the date of this program. Continuing Medical Education and Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.


CLICK HERE for a copy of the course brochure

Registration Fees: 

Registration for this event is free. Advance registration is required to receive your webinar instructions before the conference.

CLICK HERE to Register for the April  11, 2022 Session
After you complete registration an email Auto Confirmation will be sent with a "Click Here for Webinar instructions" link leading to instructions to access the webinar. Before the activity begins, please prepare your system for this event by performing a system check.

Disclosure of Ineligible Company Support
No educational grants from Ineligible Companies have been received for this course.

Accreditation Disclosure
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its accredited educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined. If any relevant financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were peer-reviewed and determined to be without ineligible company bias, were considered fair and balanced in terms of therapeutic options, and presented evidence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.

Learner Consent Statement
Names or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.